7.1% CAGR and a $1.73 Billion Race Against Time: How Cell and Advanced Therapies Supply Chain Management Is Solving the "Vein-to-Vein" Logistics Crisis to Unlock the Future of Medicine

クレジット

金金

インタビューワー